1. Neuroscience

Concurrent decoding of distinct neurophysiological fingerprints of tremor and bradykinesia in Parkinson's disease

  1. Peter M Lauro  Is a corresponding author
  2. Shane Lee
  3. Daniel E Amaya
  4. David D Liu
  5. Umer Akbar
  6. Wael F Asaad  Is a corresponding author
  1. Brown University, United States
  2. Brigham and Women's Hospital, United States
https://doi.org/10.7554/eLife.84135
Share this article
Cite this article
  1. Peter M Lauro
  2. Shane Lee
  3. Daniel E Amaya
  4. David D Liu
  5. Umer Akbar
  6. Wael F Asaad
(2023)
Concurrent decoding of distinct neurophysiological fingerprints of tremor and bradykinesia in Parkinson's disease
eLife 12:e84135.
https://doi.org/10.7554/eLife.84135
  2. Download BibTeX
  3. Download .RIS

Abstract

Parkinson's Disease (PD) is characterized by distinct motor phenomena that are expressed asynchronously. Understanding the neurophysiological correlates of these motor states could facilitate monitoring of disease progression and allow improved assessments of therapeutic efficacy, as well as enable optimal closed-loop neuromodulation. We examined neural activity in the basal ganglia and cortex of 31 subjects with PD during a quantitative motor task to decode tremor and bradykinesia - two cardinal motor signs of PD - and relatively asymptomatic periods of behavior. Support-vector regression analysis of microelectrode and electrocorticography recordings revealed that tremor and bradykinesia had nearly opposite neural signatures, while effective motor control displayed unique, differentiating features. The neurophysiological signatures of these motor states depended on the signal type and location. Cortical decoding generally outperformed subcortical decoding. Within the subthalamic nucleus (STN), tremor and bradykinesia were better decoded from distinct subregions. These results demonstrate how to leverage neurophysiology to more precisely treat PD.

Data availability

The raw datasets supporting the current study contain patient information and are unique datasets under continued investigation for additional projects, including those of junior trainees.Deidentified neural/behavioral estimates and related code to reproduce all analyses in the manuscript will be made available in a public repository (Dryad; https://doi.org/10.5061/dryad.h9w0vt4n4).To request raw datasets, please contact the corresponding authors (me@peterlauro.me, wael_asaad@brown.edu) with a project proposal. Based upon the granularity of the data requested and potential for patient information exposure, data sharing would granted in consultation with the Lifespan IRB. There are no commercial restrictions for these data currently.

The following data sets were generated

Article and author information

Author details

  1. Peter M Lauro

    Department of Neuroscience, Brown University, Providence, United States
    For correspondence
    me@peterlauro.me
    Competing interests
    Peter M Lauro, The authors have patents and patent applications (US patent #: 17312155, 17470710) broadly relevant to Parkinson's disease (but not directly based upon this work)..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8569-6427

  2. Shane Lee

    Department of Neuroscience, Brown University, Providence, United States
    Competing interests
    Shane Lee, The authors have patents and patent applications (US patent #: 17312155, 17470710) broadly relevant to Parkinson's disease (but not directly based upon this work)..

  3. Daniel E Amaya

    Department of Neuroscience, Brown University, Providence, United States
    Competing interests
    Daniel E Amaya, The authors have patents and patent applications (US patent #: 17312155, 17470710) broadly relevant to Parkinson's disease (but not directly based upon this work)..

  4. David D Liu

    Department of Neurosurgery, Brigham and Women's Hospital, Boston, United States
    Competing interests
    David D Liu, The authors have patents and patent applications (US patent #: 17312155, 17470710) broadly relevant to Parkinson's disease (but not directly based upon this work)..

  5. Umer Akbar

    Robert J and Nancy D Carney Institute for Brain Science, Brown University, Providence, United States
    Competing interests
    Umer Akbar, The authors have patents and patent applications (US patent #: 17312155, 17470710) broadly relevant to Parkinson's disease (but not directly based upon this work)..

  6. Wael F Asaad

    Department of Neuroscience, Brown University, Providence, United States
    For correspondence
    Wael_Asaad@brown.edu
    Competing interests
    Wael F Asaad, The authors have patents and patent applications (US patent #: 17312155, 17470710) broadly relevant to Parkinson's disease (but not directly based upon this work). WFA has received proprietary equipment and technical support for unrelated research through the Medtronic external research program..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4406-9096

Funding

National Institute of Neurological Disorders and Stroke (T32MH020068)

  • Peter M Lauro

Doris Duke Charitable Foundation (Clinical Scientist Development Award#2014101)

  • Wael F Asaad

National Institute of General Medical Sciences (P20 GM103645)

  • Wael F Asaad

Neurosurgery Research and Education Foundation

  • Wael F Asaad

Lifespan Norman Prince Neurosciences Institute

  • Shane Lee
  • Umer Akbar
  • Wael F Asaad

Brown University Robert J. and Nancy D. Carney Institute for Brain Science

  • Peter M Lauro
  • Shane Lee
  • Daniel E Amaya
  • Umer Akbar
  • Wael F Asaad

NIH Office of the Director (S10OD025181)

  • Wael F Asaad

Medtronic

  • Wael F Asaad

WFA has received proprietary equipment and technical support for unrelated research through the Medtronic external research program.The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Hayriye Cagnan, University of Oxford, United Kingdom

Ethics

Human subjects: Patients and control subjects agreeing to participate in this study signed informed consent, and experimental procedures were undertaken in accordance with an approved Rhode Island Hospital human research protocol (Lifespan IRB protocol #263157) and the Declaration of Helsinki.

Version history

  1. Preprint posted: February 14, 2022 (view preprint)
  2. Received: October 12, 2022
  3. Accepted: May 26, 2023
  4. Accepted Manuscript published: May 30, 2023 (version 1)
  5. Version of Record published: June 13, 2023 (version 2)

Copyright

© 2023, Lauro et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 617
    views
  • 99
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Peter M Lauro
  2. Shane Lee
  3. Daniel E Amaya
  4. David D Liu
  5. Umer Akbar
  6. Wael F Asaad
(2023)
Concurrent decoding of distinct neurophysiological fingerprints of tremor and bradykinesia in Parkinson's disease
eLife 12:e84135.
https://doi.org/10.7554/eLife.84135

Share this article

https://doi.org/10.7554/eLife.84135

Categories and tags

Research organism

Further reading

    1. Neuroscience

    FMRP regulates postnatal neuronal migration via MAP1B

    Salima Messaoudi, Ada Allam ... Isabelle Caille
    Research Article

    The fragile X syndrome (FXS) represents the most prevalent form of inherited intellectual disability and is the first monogenic cause of autism spectrum disorder. FXS results from the absence of the RNA-binding protein FMRP (fragile X messenger ribonucleoprotein). Neuronal migration is an essential step of brain development allowing displacement of neurons from their germinal niches to their final integration site. The precise role of FMRP in neuronal migration remains largely unexplored. Using live imaging of postnatal rostral migratory stream (RMS) neurons in Fmr1-null mice, we observed that the absence of FMRP leads to delayed neuronal migration and altered trajectory, associated with defects of centrosomal movement. RNA-interference-induced knockdown of Fmr1 shows that these migratory defects are cell-autonomous. Notably, the primary Fmrp mRNA target implicated in these migratory defects is microtubule-associated protein 1B (MAP1B). Knocking down MAP1B expression effectively rescued most of the observed migratory defects. Finally, we elucidate the molecular mechanisms at play by demonstrating that the absence of FMRP induces defects in the cage of microtubules surrounding the nucleus of migrating neurons, which is rescued by MAP1B knockdown. Our findings reveal a novel neurodevelopmental role for FMRP in collaboration with MAP1B, jointly orchestrating neuronal migration by influencing the microtubular cytoskeleton.

    1. Biochemistry and Chemical Biology
    2. Neuroscience

    Deciphering the chemical language of inbred and wild mouse conspecific scents

    Maximilian Nagel, Marco Niestroj ... Marc Spehr
    Research Article

    In most mammals, conspecific chemosensory communication relies on semiochemical release within complex bodily secretions and subsequent stimulus detection by the vomeronasal organ (VNO). Urine, a rich source of ethologically relevant chemosignals, conveys detailed information about sex, social hierarchy, health, and reproductive state, which becomes accessible to a conspecific via vomeronasal sampling. So far, however, numerous aspects of social chemosignaling along the vomeronasal pathway remain unclear. Moreover, since virtually all research on vomeronasal physiology is based on secretions derived from inbred laboratory mice, it remains uncertain whether such stimuli provide a true representation of potentially more relevant cues found in the wild. Here, we combine a robust low-noise VNO activity assay with comparative molecular profiling of sex- and strain-specific mouse urine samples from two inbred laboratory strains as well as from wild mice. With comprehensive molecular portraits of these secretions, VNO activity analysis now enables us to (i) assess whether and, if so, how much sex/strain-selective ‘raw’ chemical information in urine is accessible via vomeronasal sampling; (ii) identify which chemicals exhibit sufficient discriminatory power to signal an animal’s sex, strain, or both; (iii) determine the extent to which wild mouse secretions are unique; and (iv) analyze whether vomeronasal response profiles differ between strains. We report both sex- and, in particular, strain-selective VNO representations of chemical information. Within the urinary ‘secretome’, both volatile compounds and proteins exhibit sufficient discriminative power to provide sex- and strain-specific molecular fingerprints. While total protein amount is substantially enriched in male urine, females secrete a larger variety at overall comparatively low concentrations. Surprisingly, the molecular spectrum of wild mouse urine does not dramatically exceed that of inbred strains. Finally, vomeronasal response profiles differ between C57BL/6 and BALB/c animals, with particularly disparate representations of female semiochemicals.

    1. Neuroscience

    Functional diversity of dopamine axons in prefrontal cortex during classical conditioning

    Kenta Abe, Yuki Kambe ... Tatsuo Sato
    Research Article

    Midbrain dopamine neurons impact neural processing in the prefrontal cortex (PFC) through mesocortical projections. However, the signals conveyed by dopamine projections to the PFC remain unclear, particularly at the single-axon level. Here, we investigated dopaminergic axonal activity in the medial PFC (mPFC) during reward and aversive processing. By optimizing microprism-mediated two-photon calcium imaging of dopamine axon terminals, we found diverse activity in dopamine axons responsive to both reward and aversive stimuli. Some axons exhibited a preference for reward, while others favored aversive stimuli, and there was a strong bias for the latter at the population level. Long-term longitudinal imaging revealed that the preference was maintained in reward- and aversive-preferring axons throughout classical conditioning in which rewarding and aversive stimuli were paired with preceding auditory cues. However, as mice learned to discriminate reward or aversive cues, a cue activity preference gradually developed only in aversive-preferring axons. We inferred the trial-by-trial cue discrimination based on machine learning using anticipatory licking or facial expressions, and found that successful discrimination was accompanied by sharper selectivity for the aversive cue in aversive-preferring axons. Our findings indicate that a group of mesocortical dopamine axons encodes aversive-related signals, which are modulated by both classical conditioning across days and trial-by-trial discrimination within a day.